Pharmabiz

Care ADHD to open its first clinic, bringing NHS-backed ADHD care model to India

Care ADHD to open its first clinic, bringing NHS-backed ADHD care model to India: Our Bureau, Bengaluru Wednesday, August 5, ...
Pharmabiz

PCI extends timeline till August 31 for completion of approval process for 2026-27

PCI extends timeline till August 31 for completion of approval process for 2026-27: Gireesh Babu, New Delhi Wednesday, August ...
Pharmabiz

CervoMed’s neflamapimod awarded Innovation Passport Designation under the UK ILAP for treatment of dementia with Lewy bodies

CervoMed’s neflamapimod awarded Innovation Passport Designation under the UK ILAP for treatment of dementia with Lewy bodies: Boston Wednesday, August 5, 2026, 18:00 Hrs [IST] C ...
Pharmabiz

Healthium Medtech appoints Gaurav Goel as CEO and MD; Anish Bafna promoted as non-executive chairman

Healthium Medtech appoints Gaurav Goel as CEO and MD; Anish Bafna promoted as non-executive chairman: Our Bureau, Bengaluru Wednesday, August 5, 2026, 16:45 Hrs [IST] Healthium Me ...
Pharmabiz

Pathos AI inks collaboration and co-exclusive licensing agreement with AstraZeneca to advance novel ERa PROTAC for ER+ breast cancer into the clinic

Pathos AI inks collaboration and co-exclusive licensing agreement with AstraZeneca to advance novel ERa PROTAC for ER+ breast cancer into the clinic: New York Wednesday, August 5, ...
Pharmabiz

Evexta Bio enters clinical trial collaboration and supply agreement with Roche to evaluate rupitasertib in combo with a SERD in advanced/metastatic breast cancer

Evexta Bio enters clinical trial collaboration and supply agreement with Roche to evaluate rupitasertib in combo with a SERD in advanced/metastatic breast cancer: Paris Wednesday, ...
Pharmabiz

4Moving Biotech completes enrollment in phase 2a INFLAM MOTION study evaluating first-in-class intra-articular GLP-1 therapy?targeting synovitis as a driver of pain and disease ...

Moving Biotech completes enrollment in phase 2a INFLAM MOTION study evaluating first-in-class intra-articular GLP-1 therapy?targeting synovitis as a driver of pain and disease pr ...
Pharmabiz

Cipla's InvaGen Pharma receives EIR from US FDA for New York facility

Cipla's InvaGen Pharma receives EIR from US FDA for New York facility: Our Bureau, Mumbai Wednesday, August 5, 2026, 15:15 Hrs [IST] Cipla Ltd announced that InvaGen Pharmaceutica ...
Pharmabiz

Health ministry deploys National Joint Outbreak Response team for Chandipura virus outbreak

The Union ministry of health and family welfare has deployed a National Joint Outbreak Response Team (NJORT) to Gujarat and Rajasthan to strengthen the response to the ongoing Chandipura Virus Disease ...
Pharmabiz

Drone-assisted TB sample transport reduces diagnosis time and cost significantly, says ICMR study

Drone-assisted TB sample transport reduces diagnosis time and cost significantly, says ICMR study: Our Bureau, New Delhi Wednesday, August 5, 2026, 16:20 Hrs [IST] As per the late ...
Pharmabiz

Livlong 365 debuts SurgiCare to simplify planned surgeries and post-operative care

Livlong 365 debuts SurgiCare to simplify planned surgeries and post-operative care: Our Bureau, Mumbai Wednesday, August 5, 2026, 14:50 Hrs [IST] Livlong 365, a digital-first heal ...
Pharmabiz

Pondicherry govt appoints Dr V Rajendran as licensing and controlling authority to restart regulatory operations

Pondicherry govt appoints Dr V Rajendran as licensing and controlling authority to restart regulatory operations: Our Bureau, Chennai Wednesday, August 5, 2026, 15:40 Hrs [IST] In ...